{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:25:17Z","timestamp":1787955917272,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003500","name":"University of Padua","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jtha.2023.06.033","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T21:09:17Z","timestamp":1688677757000},"page":"3138-3144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Close link between antiphosphatidylserine\/prothrombin antibodies, lupus anticoagulant, and activated protein C resistance in tetra antiphospholipid antibody\u2013positive subjects"],"prefix":"10.1016","volume":"21","author":[{"given":"Elena","family":"Pontara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Bison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Cattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Tonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gentian","family":"Denas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Pengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.06.033_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.033_bib2","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/1529-0131(200009)43:9<1982::AID-ANR9>3.0.CO;2-2","article-title":"Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant","volume":"43","author":"Atsumi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtha.2023.06.033_bib3","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1160\/TH13-06-0509","article-title":"Anti-prothrombin (aPT) and anti-phosphatidylserine\/prothrombin (aPS\/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review","volume":"111","author":"Sciascia","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.033_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.thromres.2019.03.006","article-title":"IgG phosphatidylserine\/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers","volume":"177","author":"Tonello","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.06.033_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.thromres.2022.04.021","article-title":"Prevalence of aPhosphatidylserine\/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: a systematic review and meta-analysis","volume":"214","author":"Zhu","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.06.033_bib6","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/jth.14765","article-title":"Tetra positive thrombotic antiphospholipid syndrome: major contribution of anti-phosphatidyl-serine\/prothrombin antibodies to lupus anticoagulant activity","volume":"18","author":"Cattini","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.033_bib7","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1111\/jth.14896","article-title":"Additional laboratory tests to improve on the diagnosis of antiphospholipid syndrome","volume":"18","author":"Pengo","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.033_bib8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/jth.15199","article-title":"Insight into the hypercoagulable state of high-risk thrombotic APS patients: contribution of abeta2GPI and aPS\/PT antibodies","volume":"19","author":"Pontara","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.033_bib9","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1182\/blood-2011-03-340232","article-title":"Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study","volume":"118","author":"Pengo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.06.033_bib10","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.06.033_bib11","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/jth.12537","article-title":"Subcommittee on Lupus Anticoagulant\/Phospholipid\/Dependent Antibodies. Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH","volume":"12","author":"Devreese","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.033_bib12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.thromres.2018.11.003","article-title":"Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns","volume":"172","author":"Pengo","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.06.033_bib13","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","volume":"7","author":"Pengo","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.033_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.thromres.2016.01.019","article-title":"Mixing test specific cut-off is more sensitive at detecting lupus anticoagulants than index of circulating anticoagulant","volume":"139","author":"Moore","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.06.033_bib15","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.033_bib16","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/jth.15287","article-title":"Recommendations for the measurement of thrombin generation: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"19","author":"Ninivaggi","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.033_bib17","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/jth.13379","article-title":"IgG\/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis","volume":"14","author":"Kelchtermans","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.033_bib18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.thromres.2015.08.019","article-title":"The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome","volume":"136","author":"Del Ross","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.06.033_bib19","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1161\/STROKEAHA.118.023021","article-title":"Antiphospholipid syndrome with isolated isotype M anticardiolipin and\/or anti-b2gpi antibody is associated with stroke","volume":"49","author":"Urbanski","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2023.06.033_bib20","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/acr.24520","article-title":"Development of a new international antiphospholipid syndrome classification criteria phase I\/II report: generation and reduction of candidate criteria","volume":"73","author":"Barbhaiya","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jtha.2023.06.033_bib21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/acr.23310","article-title":"First-line, non-criterial antiphospholipid antibody testing for the diagnosis of antiphospholipid syndrome in clinical practice: a combination of anti\u2013\u03b22-glycoprotein I domain I and anti\u2013phosphatidylserine\/prothrombin complex antibodies tests","volume":"70","author":"Nakamura","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jtha.2023.06.033_bib22","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/jth.15785","article-title":"Added value of antiphosphatidylserine\/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: communication from the ISTH SSC subcommittee on lupus anticoagulant\/antiphospholipid antibodies","volume":"20","author":"Vandevelde","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.033_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12676","article-title":"Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants","volume":"6","author":"Favaloro","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.033_bib24","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2141.2011.08990.x","article-title":"False prolongation of the activated partial thromboplastin time (aPTT) in inflammatory patients: interference of C-reactive protein","volume":"157","author":"van Rossum","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.06.033_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000065217","article-title":"Abnormally short activated partial thromboplastin times are related to elevated plasma levels of TAT, F1+2, D-dimer and FVIII:C","volume":"32","author":"Ten Boekel","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.jtha.2023.06.033_bib26","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1055\/s-0040-1705091","article-title":"Prothrombin is responsible for the lupus cofactor phenomenon in a patient with lupus anticoagulant\/hypoprothrombinemia syndrome","volume":"4","author":"Pengo","year":"2020","journal-title":"TH Open"},{"key":"10.1016\/j.jtha.2023.06.033_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1055\/s-0032-1304717","article-title":"To mix or not to mix in lupus anticoagulant testing? That is the question","volume":"38","author":"Tripodi","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.06.033_bib28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1055\/s-0041-1742083","article-title":"Interaction between antiphospholipid antibodies and protein C anticoagulant pathway: a narrative review","volume":"48","author":"Pengo","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.06.033_bib29","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1182\/bloodadvances.2019030932","article-title":"Discovery and characterization of 2 novel subpopulations of aPS\/PT antibodies in patients at high risk of thrombosis","volume":"3","author":"Chinnaraj","year":"2019","journal-title":"Blood Adv"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623005196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623005196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:39:42Z","timestamp":1761536382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623005196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1538783623005196"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.06.033","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Close link between antiphosphatidylserine\/prothrombin antibodies, lupus anticoagulant, and activated protein C resistance in tetra antiphospholipid antibody\u2013positive subjects","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}